Forian Inc

NASDAQ FORA

Download Data

Forian Inc Enterprise Value to EBITDA (EV/EBITDA) on June 03, 2024: -17.91

Forian Inc Enterprise Value to EBITDA (EV/EBITDA) is -17.91 on June 03, 2024, a -253.48% change year over year. The EV/EBITDA ratio compares a company's enterprise value to its EBITDA. It provides insight into the company's valuation relative to its earnings and is commonly used in comparing the relative value of different companies within an industry. A lower ratio suggests a potentially more favorable valuation.
  • Forian Inc 52-week high Enterprise Value to EBITDA (EV/EBITDA) is -4.23 on June 27, 2023, which is 76.39% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • Forian Inc 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -22.22 on April 03, 2024, which is -24.05% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Forian Inc average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -11.73.
NASDAQ: FORA

Forian Inc

CEO Mr. Daniel J. Barton
IPO Date March 3, 2021
Location United States
Headquarters 41 University Drive, Newtown, PA, United States, 18940
Employees 36
Sector Healthcare
Industry Health information services
Description

Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharma services, and healthcare payer and provider industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.

Similar companies

HQY

HealthEquity Inc

USD 81.22

-0.56%

MDRX

Veradigm Inc.

USD 9.60

1.05%

StockViz Staff

July 25, 2024

Any question? Send us an email